Treg versus Th17 lymphocyte lineages are cross-regulated by LIF versus IL-6. - Wikidata - wikimedia - TriplyDB

Treg versus Th17 lymphocyte lineages are cross-regulated by LIF versus IL-6.

Treg versus Th17 lymphocyte lineages are cross-regulated by LIF versus IL-6.

http://www.wikidata.org/entity/Q33896981

about

Particle-mediated delivery of cytokines for immunotherapy A herpes simplex virus-derived replicative vector expressing LIF limits experimental demyelinating disease and modulates autoimmunity Remyelination Is Correlated with Regulatory T Cell Induction Following Human Embryoid Body-Derived Neural Precursor Cell Transplantation in a Viral Model of Multiple Sclerosis Micro and nanoparticle drug delivery systems for preventing allotransplant rejection Diet-induced obesity alters dendritic cell function in the presence and absence of tumor growth Serum Cytokines as Biomarkers in Islet Cell Transplantation for Type 1 Diabetes LIF-dependent signaling: new pieces in the Lego Oral Administration of Heat-Killed Mycobacterium manresensis Delays Progression toward Active Tuberculosis in C3HeB/FeJ Mice.Resistin enhances the expansion of regulatory T cells through modulation of dendritic cells.The E3 ligase axotrophin/MARCH-7: protein expression profiling of human tissues reveals links to adult stem cells A LIF/Nanog axis is revealed in T lymphocytes that lack MARCH-7, a RINGv E3 ligase that regulates the LIF-receptor.Modelling of a targeted nanotherapeutic 'stroma' to deliver the cytokine LIF, or XAV939, a potent inhibitor of Wnt-β-catenin signalling, for use in human fetal dopaminergic grafts in Parkinson's disease.Immuno-isolation of pancreatic islet allografts using pegylated nanotherapy leads to long-term normoglycemia in full MHC mismatch recipient mice Axotrophin/MARCH7 acts as an E3 ubiquitin ligase and ubiquitinates tau protein in vitro impairing microtubule binding.Leukemia inhibitory factor downregulates human papillomavirus-16 oncogene expression and inhibits the proliferation of cervical carcinoma cells.Transplantation tolerance: Clinical potential of regulatory T cells.Cell-Intrinsic gp130 Signaling on CD4+ T Cells Shapes Long-Lasting Antiviral Immunity Leukemia inhibitory factor signaling is required for lung protection during pneumonia Allograft rejection is restrained by short-lived TIM-3+PD-1+Foxp3+ Tregs.The serum IL-6 profile and Treg/Th17 peripheral cell populations in patients with type 1 diabetes.Changes in T-cell subsets identify responders to FcR-nonbinding anti-CD3 mAb (teplizumab) in patients with type 1 diabetes RNA in blood is altered prior to hemorrhagic transformation in ischemic stroke Enhancement of surface ligand display on PLGA nanoparticles with amphiphilic ligand conjugates An update on regulatory T cells in transplant tolerance and rejection.LIF in the regulation of T-cell fate and as a potential therapeutic.Learning to live together: harnessing regulatory T cells to induce organ transplant tolerance.Immunomodulatory properties of the IL-6 cytokine family in multiple sclerosis.Infusion of umbilical cord mesenchymal stem cells alleviates symptoms of ankylosing spondylitis.The Membrane Associated RING-CH Proteins: A Family of E3 Ligases with Diverse Roles through the Cell.Myelin repair in vivo is increased by targeting oligodendrocyte precursor cells with nanoparticles encapsulating leukaemia inhibitory factor (LIF)Exposure to perfluoroundecanoic acid (PFUnDA) accelerates insulitis development in a mouse model of type 1 diabetes.Effects of nanosilver exposure on cholinesterase activities, CD41, and CDF/LIF-like expression in zebrafish (Danio rerio) larvae.Neurodegenerative Disease: A Perspective on Cell-Based Therapy in the New Era of Cell-Free Nano-Therapy.Human intrahepatic regulatory T cells are functional, require IL-2 from effector cells for survival, and are susceptible to Fas ligand-mediated apoptosis Synergy between IL-6 and TGF-β signaling promotes FOXP3 degradation.Modulation of CD4+ T lymphocyte lineage outcomes with targeted, nanoparticle-mediated cytokine delivery.Regulation of the Mdm2-p53 pathway by the ubiquitin E3 ligase MARCH7.Stem cell therapy versus T lymphocytes: friend or foe?Regulation of T-Cell Signaling by Post-Translational Modifications in Autoimmune Disease.Microenvironmental regulation of oligodendrocyte replacement and remyelination in spinal cord injury.

P2860

Q26997993-BBF58215-649E-4CA2-9DEC-7D051E4384E3 Q27319470-D4878A48-9576-4D76-B988-813FB61C0C93 Q27339236-75626A9A-F113-4A39-BB4D-35CECE989FFB Q28080720-9259E2D8-AA4D-429B-BC06-014824B7487D Q28386614-2E0ADDB6-8C34-4206-82D9-6F5282B64D45 Q28552483-3CDE6A0E-FAB2-4A1D-8A79-F1963B071F2D Q28731796-B3741022-670E-4A9E-A898-C569E49A2D70 Q31037455-D1C9C2ED-94FE-4E3C-A929-CC63C5065271 Q33622026-F0B6F2AE-3557-4C7F-BD3E-BA1EA8A5851D Q33742767-5BED7ACF-0A30-4F6F-AD23-8E0C5F65EC18 Q34144795-50922989-3416-4F5F-978C-37ACE915DDD7 Q34241152-81E4333B-DA22-41C3-9100-83BE4AD62A7E Q34506953-02B93F1D-1329-4E77-B916-0B21B60E7C5D Q35029202-96DD3D8F-61E8-432A-8B69-61BC932B1B0C Q35070591-E9F7CC9F-5149-4D31-B761-C11540057294 Q35107006-8000A99C-00DE-4E11-AA45-F3FCAC0EE701 Q35864505-5BCB96DE-54EC-449C-A3FD-825554A14EE7 Q36016336-887EE909-C64F-43AE-BD03-04AEB07EB5B9 Q36068258-865AA986-F727-4194-9F50-10EE7B95C4AF Q36679011-B5C11754-2B06-43A7-A52D-B498822AD2B7 Q36940282-1E230813-4349-4D72-AC75-AAF0DFBD2C12 Q37118070-C0B76C25-E0DC-4099-BE69-3EE1489C54AC Q37238542-8661ACD8-DEE9-4771-9FF9-C13978F1CF8E Q37777645-E683D427-4CBA-4672-B09A-D9675BC46C19 Q37849132-36DB153E-AAED-4A99-9A9C-CF6118A4C363 Q37969741-D1276AFB-6B45-4F0E-BC83-24E462FC911D Q38534740-0475DD30-11FC-4F2A-853D-1403E2CE4D49 Q38646267-693D25B9-9AF1-4547-87AB-99B6412D976A Q38897631-AB1216A1-59F9-4BA6-BBD2-68E54419748C Q40617937-B1BA3021-A5C9-4F31-8C5C-890B975DCACE Q41679312-C0BCF389-2AB5-4124-B95E-B75E0197FA6B Q41895340-103B8367-33FE-4D10-B484-32116C804CEB Q42065629-05A6FB9C-E479-423B-BA82-4E691AEA6FB3 Q42108248-895334B2-E32E-4430-91FD-87D0A0424894 Q42324467-1664F6C4-0A01-4643-8DD9-527FB063BCD4 Q42607562-B3AB9A73-E1E4-4D7F-83B9-C83A68853EB7 Q48319353-43EE1299-CF14-4495-A30C-7E449798FD5E Q48490621-B7205A42-1B38-4F61-8437-05D8FF6FDF63 Q52689527-6B08BAA0-2175-4802-A8A6-C3DFB3DD46CC Q53180449-3B8CF83D-44A8-40B7-B1B3-4A9CA019C3C8

P2860

Treg versus Th17 lymphocyte lineages are cross-regulated by LIF versus IL-6.

http://www.wikidata.org/entity/Q33896981

description

2009 nî lūn-bûn

@nan

2009 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Treg versus Th17 lymphocyte lineages are cross-regulated by LIF versus IL-6.

@ast

Treg versus Th17 lymphocyte lineages are cross-regulated by LIF versus IL-6.

@en

type

label

Treg versus Th17 lymphocyte lineages are cross-regulated by LIF versus IL-6.

@ast

Treg versus Th17 lymphocyte lineages are cross-regulated by LIF versus IL-6.

@en

prefLabel

Treg versus Th17 lymphocyte lineages are cross-regulated by LIF versus IL-6.

@ast

Treg versus Th17 lymphocyte lineages are cross-regulated by LIF versus IL-6.

@en

P1433

Q33896981-46B6345F-DFB2-445D-A539-F92BC00349DE

P1476

Q33896981-2BBB9139-777C-4FBF-8F1F-E9EAF17558B7

P2093

Q33896981-1856BDAA-07D7-42E5-97A3-2E3D0A5D5571

Q33896981-428B5455-82E1-4F96-A579-DC3ADB0981AA

Q33896981-6344FCD7-AAB5-4F16-99A3-5BA1D2BC9E02

Q33896981-8280F182-560A-411E-850E-BD1843ACE3EC

Q33896981-A64FF3FC-2B04-461E-AD61-8B4FC8C1BD7F

Q33896981-CB06E29C-F859-498E-97FA-6D72BD759FE3

Q33896981-D2ADE952-3957-479C-B53D-4936DD36401F

P2860

Q33896981-005FAA43-A698-4E76-9F7B-196B66354A61

Q33896981-09D3D029-0E52-4E24-8721-9C2BC7056236

Q33896981-1897EB5B-B0A1-411D-8479-E477E99ADEDC

Q33896981-2BF8CB1F-BF31-45E1-8C36-5A7B60914113

Q33896981-31077376-9C55-4FF7-B6BE-4556B2AEA461

Q33896981-3730B865-C95F-4612-A50E-1A841EE7CBAF

Q33896981-4895FC77-EE05-4469-9AE9-B0610357A61B

Q33896981-5B08F7D9-2C7D-4FCF-AC5B-C13C9289BABC

Q33896981-5D7E5E58-EED7-49C6-A2DA-E0758129236D

Q33896981-7C979143-2DCF-4156-8940-CE84D8236D66

P304

Q33896981-0820F020-AA18-4D84-8FDA-BDC5D3FAD76F

P31

Q33896981-D6C14604-AE0E-45CB-8418-1C20FDEBA08E

P356

Q33896981-4C66AD54-70B7-4067-BC1E-B14188BBA437

P433

Q33896981-F117569B-092E-42A0-963A-1DAA5C62814D

P478

Q33896981-71468F9F-4476-4FE8-B016-46EA99ED83A9

P577

Q33896981-D065D4A4-0B77-4460-B5C2-C5546DED6384

P5875

Q33896981-6879FA62-47A6-4C6E-A7BD-2DC10A5EA916

P698

Q33896981-6AB3474D-F1A5-47CF-99A5-8C83EAC9097F

P932

Q33896981-849AAC63-B55A-4C88-9E29-6D1E2983900A

P356

P1433

P1476

Treg versus Th17 lymphocyte lineages are cross-regulated by LIF versus IL-6.

@en

P2093

Lorraine Thompson

http://www.w3.org/2001/XMLSchema#string

Prabhakar Putheti

http://www.w3.org/2001/XMLSchema#string

Qiang Zhou

http://www.w3.org/2001/XMLSchema#string

Su M Metcalfe

http://www.w3.org/2001/XMLSchema#string

Tarek M Fahmy

http://www.w3.org/2001/XMLSchema#string

Terry B Strom

http://www.w3.org/2001/XMLSchema#string

Wenda Gao

http://www.w3.org/2001/XMLSchema#string

P2860

Downregulation of major histocompatibility complex class I by human ubiquitin ligases related to viral immune evasion proteins

Principles of interleukin (IL)-6-type cytokine signalling and its regulation

Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells

Control of regulatory T cell development by the transcription factor Foxp3

The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells

Foxp3 programs the development and function of CD4+CD25+ regulatory T cells

TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells

Leukaemia inhibitory factor (LIF) is functionally linked to axotrophin and both LIF and axotrophin are linked to regulatory immune tolerance

Regulatory T cells and immune tolerance

An essential role for Scurfin in CD4+CD25+ T regulatory cells

P304

1444-1450

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4161/CC.8.9.8348

http://www.w3.org/2001/XMLSchema#string

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

8

http://www.w3.org/2001/XMLSchema#string

P577

2009-05-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

24254420

http://www.w3.org/2001/XMLSchema#string

P698

19342884

http://www.w3.org/2001/XMLSchema#string

P932

2881570

http://www.w3.org/2001/XMLSchema#string